Stonepine Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
Stonepine Capital Management's OCUL Position: Q3 2026 in Review
Stonepine Capital Management opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 20,000 shares worth $153K. The stake represents 0.1% of the portfolio and ranks #71 among its holdings.
263 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Stonepine Capital Management held 20,000 shares of Ocular Therapeutix worth $153K as of Q3 2026.
- Ocular Therapeutix was a new Stonepine Capital Management position in Q3 2026.
- Ocular Therapeutix made up 0.1% of Stonepine Capital Management's portfolio in Q3 2026, its #71 holding.
- 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Stonepine Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.